CARTALAX 20MG

Cartalax is a synthetic peptide bioregulator originally developed in Russia. It belongs to a class of short peptides that are designed to interact with specific genes or tissues to help regulate biological functions. Cartalax is particularly associated with cartilage tissue and joint health.

What It Is

Type: Synthetic peptide (bioregulator).

Origin: Developed in peptide research institutes in Russia.

Target: Cartilage and connective tissue.

Mechanism: Works at the genetic level to regulate protein synthesis in cartilage cells (chondrocytes), supporting regeneration and repair.

Reported Benefits

While much of the available research is preclinical or from Russian studies, Cartalax has been described as providing:

1. Joint Health Support

Helps maintain the function and integrity of cartilage tissue.

2. Anti-Inflammatory Effects

May reduce inflammation in joints and connective tissue, aiding in comfort and mobility.

3. Tissue Regeneration

Supports repair and regeneration of cartilage, which is useful in conditions involving cartilage degeneration (like osteoarthritis).

4. Improved Mobility

Some studies suggest it may enhance joint flexibility and reduce stiffness.

5. Potential Anti-Aging Effect on Connective Tissue

By regulating gene expression, it may slow down age-related decline in cartilage and joint structures.

---

⚠️ Important Note: Cartalax, like other peptide bioregulators, is marketed for research purposes only in many countries. Clinical use in humans is not widely approved outside of certain regions. Most benefits are based on experimental studies, Russian clinical trials, and anecdotal reports rather than large-scale Western clinical trials.